Meridian Bioscience reported $68.48M in Gross Profit on Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Abbott ABT:US $ 6908M 160M
Accelerate Diagnostics AXDX:US 802K 380K
Atrion ATRI:US 17.38M 414K
Becton, Dickinson and BDX:US $ 2305M 118M
Bio Rad Laboratories BIO:US $ 403.56M 2.66M
Cerus CERS:US $ 24.94M 5.67M
Meridian Bioscience VIVO:US $ 68.48M 19.32M
Myriad Genetics MYGN:US $ 115M 4.5M
Orasure Technologies OSUR:US $ 24.27M 2.86M
Quidel QDEL:US $ 739.96M 250.62M
Sientra SIEN:US 12.84M 518K
Thermo Fisher Scientific TMO:US $ 5464M 210M